Apellis Pharmaceuticals, Inc.

Nasdaq:APLS

Pharmaceutical Preparations·WALTHAM, MA

CEO

Francois Cedric

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/24/26	→
10-Q	Q3 2025	9/30/25	10/30/25	→
10-Q	Q2 2025	6/30/25	7/31/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K	FY 2024	12/31/24	2/28/25	→
10-Q	Q3 2024	9/30/24	11/5/24	→
↓

Earnings Releases (8-K)

8 shown

Filed	Period
1/12/26	Q4 FY2026	→
1/13/25	Q4 FY2025	→
2/27/24	Q1 FY2024	→
1/8/24	Q4 FY2024	→
10/5/23	Q3 FY2023	→
7/31/23	Q2 FY2023	→
↓

News (8-K)

46 shown

Filed	Type	Description
3/2/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/1/25	Agreement	Entry into a Material Definitive Agreement	→
6/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
4/21/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/8/24	Other	Other Events	→
6/5/24	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

23 shown

Filed	Form	Description
2/24/26	S-8	S-8	→
4/23/25	ARS	ARS	→
2/28/25	S-8	S-8	→
4/26/24	ARS	ARS	→
2/27/24	S-8	S-8	→
11/1/23	424B5	424B5	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

Mar 3, 2026

0001492422-26-000092PRIMARY DOCUMENT

Feb 27, 2026

6.7 KB

Mar 3, 2026

0001492422-26-000091PRIMARY DOCUMENT

Mar 2, 2026

6.6 KB

8-K

Mar 2, 2026

0001193125-26-0841568-K

Feb 27, 2026

134.0 KB

S-8

Feb 24, 2026

0001193125-26-065202S-8

—

171.7 KB

10-K

Feb 24, 2026

0001193125-26-06517910-K

Dec 31, 2025

18.7 MB

SCHEDULE 13G

Feb 17, 2026

0001493215-26-000026

—

12.2 KB

Feb 13, 2026

0001492422-26-000083PRIMARY DOCUMENT

Feb 11, 2026

4.4 KB

144

Feb 11, 2026

0001959173-26-000886

—

6.0 KB

SCHEDULE 13G

Feb 6, 2026

0002012383-26-000899

—

10.7 KB

Feb 5, 2026

0001492422-26-000081PRIMARY DOCUMENT

Feb 3, 2026

10.8 KB

Jan 30, 2026

0001492422-26-000079PRIMARY DOCUMENT

Jan 28, 2026

4.4 KB

Jan 30, 2026

0001492422-26-000078PRIMARY DOCUMENT

Jan 28, 2026

4.4 KB

Jan 30, 2026

0001492422-26-000077PRIMARY DOCUMENT

Jan 28, 2026

4.4 KB

Jan 30, 2026

0001492422-26-000076PRIMARY DOCUMENT

Jan 28, 2026

4.5 KB

Jan 30, 2026

0001492422-26-000075PRIMARY DOCUMENT

Jan 28, 2026

4.5 KB

Jan 30, 2026

0001492422-26-000074PRIMARY DOCUMENT

Jan 28, 2026

4.5 KB

Jan 30, 2026

0001492422-26-000073PRIMARY DOCUMENT

Jan 28, 2026

5.6 KB

Jan 30, 2026

0001492422-26-000072PRIMARY DOCUMENT

Jan 28, 2026

7.5 KB

Jan 30, 2026

0001492422-26-000071PRIMARY DOCUMENT

Jan 28, 2026

8.9 KB

Jan 23, 2026

0001492422-26-000061PRIMARY DOCUMENT

Jan 22, 2026

4.4 KB

Jan 23, 2026

0001492422-26-000060PRIMARY DOCUMENT

Jan 22, 2026

4.4 KB

Jan 23, 2026

0001492422-26-000059PRIMARY DOCUMENT

Jan 22, 2026

4.4 KB

Jan 23, 2026

0001492422-26-000058PRIMARY DOCUMENT

Jan 22, 2026

4.4 KB

Jan 23, 2026

0001492422-26-000057PRIMARY DOCUMENT

Jan 22, 2026

8.9 KB

Jan 23, 2026

0001492422-26-000056PRIMARY DOCUMENT

Jan 22, 2026

4.4 KB

25 filings shown

Apellis Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/23/25	DEFA14A	DEFA14A	→
4/23/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/21/23	DEFA14A	DEFA14A	→
4/21/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
3/3/26	4	PRIMARY DOCUMENT	→
3/3/26	3	PRIMARY DOCUMENT	→
2/13/26	4	PRIMARY DOCUMENT	→
2/5/26	4	PRIMARY DOCUMENT	→
1/30/26	4	PRIMARY DOCUMENT	→
1/30/26	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/11/26	144	144	→
2/6/26	SCHEDULE 13G	SCHEDULE 13G	→
1/22/26	144	144	→
1/22/26	144	144	→
1/22/26	144	144	→
↓